Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

41.95 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Moderna, Inc. - Common Stock

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
99 100 Next >
News headline image
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer ↗
Viking Therapeutics is an upstart in the weight-loss drugs space. But it's catching attention. 
Via Investor's Business Daily
News headline image
Alnylam's Concedes Its Patent Infringement Case Against Moderna's COVID-19 Vaccine ↗
Alnylam Pharmaceuticals has conceded that Moderna's products do not infringe on its patents, as a court ruling determined. Both companies have agreed to dismiss the case without prejudice for possible... 
Via Benzinga
Topics Intellectual Property
News headline image
Is It Time to Buy September's Worst-Performing S&P 500 Stocks? ↗
Could rebounds be in store for these beaten-down stocks? 
Via The Motley Fool
Topics Stocks
News headline image
The Covid Era Tech Promises To Reinvent Cancer Treatment ↗
Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. 
Via Benzinga
News headline image
3 Surprisingly Underrated Stocks to Buy Right Now ↗
These stocks might look like bad picks. But appearances can be deceiving. 
Via The Motley Fool
News headline image
Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
16 Analysts Have This To Say About Moderna ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
Top 3 Health Care Stocks That May Explode This Month ↗
 
Via Benzinga
News headline image
2 Beaten-Down Stocks to Buy and Hold for a Decade ↗
These innovative companies have the tools to rebound. 
Via The Motley Fool
News headline image
Pfizer Advances On Its Cancer Journey ↗
On Saturday, Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer cachexia during the European Society for Medical Oncology 2024... 
Via Benzinga
News headline image
Down 13% in 1 Day, Is Moderna Stock in Trouble? ↗
There's no hope of it recovering to its prior heights anytime soon. 
Via The Motley Fool
News headline image
Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks ↗
This strategic play will take time to pay off, but it could keep growth going. 
Via The Motley Fool
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Tradepulse Power Inflow Alert: Moderna Inc. Rises 8.9% On The Trading Day ↗
 
Via Benzinga
News headline image
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse ↗
Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity Residential. Moderna has been disappointing, but Cramer likes Vertiv and... 
Via Benzinga
News headline image
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 ↗
These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond. 
Via The Motley Fool
News headline image
S&P 500 Briefly Hits Record High Just Ahead Of Fed Rate Cut, Extends 7-Day Winning Streak: Tuesday's Top 5 Gainers ↗
S&P 500 hits new record highs amidst expectations for Fed interest rate decision. Small-cap stocks outperform, while uncertainty remains. 
Via Benzinga
Topics Economy Stocks
News headline image
Momentum Investing Gives You An Edge, Until It Doesn’t ↗
Since 2020, momentum investing has generated significantly better returns than other strategies. Such is not surprising, given the massive amounts of stimulus injected into the financial system. 
Via Talk Markets
News headline image
Small Caps, Bitcoin Rally As Traders Await Fed Rate Cut; Treasury Yields, US Dollar Tick Up On Strong Retail Sales: What's Driving Markets Tuesday? ↗
Wall Street experienced a slightly positive session Tuesday, supported by investor optimism as the Federal Open Market Committee (FOMC) kicked off its two-day meeting, expected to deliver the first... 
Via Benzinga
Topics Economy
News headline image
What's Going On With Moderna Shares Tuesday? ↗
Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 vaccine. 
Via Benzinga
News headline image
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions ↗
Florida advises against mRNA Covid vaccines for vulnerable residents, citing safety concerns. Gov. DeSantis' administration urges healthcare providers to prioritize alternative vaccines for seniors and... 
Via Benzinga
News headline image
Moderna, Tyson Foods And Adobe Are Among Top 10 Large Cap Stock Losers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio? ↗
10 worst performing large-cap stocks last week: RTO, ALLY, MRNA, HUM, TSN, BEKE, ADBE, RYAAY, JPM, DVN. Consider impact on your portfolio. 
Via Benzinga
News headline image
Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path? ↗
This highflier has fallen on hard times recently. 
Via The Motley Fool
News headline image
Wall Street's Top 10 Stock Calls This Week - Saturday, Sept. 14 ↗
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Sept. 9-13, 2024. 
Via Talk Markets
News headline image
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More ↗
Financial factors aren't the only things that are worth paying attention to. 
Via The Motley Fool
News headline image
After Moderna's Shocking News, Is the Stock a Buy or a Sell? ↗
Moderna held its annual R&D day this week. 
Via The Motley Fool
News headline image
Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target ↗
Moderna announces plans to reduce R&D spending by $1.1 billion by 2027, focusing on ten key products. Analysts highlight near-term challenges, lowered price targets, and a delayed breakeven to 2028,... 
Via Benzinga
News headline image
Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday ↗
 
Via Benzinga
News headline image
Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day ↗
The company offered a series of updates that shook shares on Thursday. The selloff continued on Friday. 
Via Investor's Business Daily
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.